Protein Science Sheba protein
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print October 31, 2005, 10.1110/ps.051622005
Protein Science (2005), 14:2993-3003. Published by Cold Spring Harbor Laboratory Press. Copyright © 2005 The Protein Society
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Research Data
Right arrow All Versions of this Article:
ps.051622005v1
14/12/2993    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galea, C.
Right arrow Articles by Kriwacki, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galea, C.
Right arrow Articles by Kriwacki, R. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Disruption of an intermonomer salt bridge in the p53 tetramerization domain results in an increased propensity to form amyloid fibrils

Charles Galea1, Prentice Bowman1 and Richard W. Kriwacki1,2

1 Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, USA
2 Department of Molecular Sciences, University of Tennessee Health Sciences Center, Memphis, Tennessee 38163, USA

(RECEIVED June 1, 2005; FINAL REVISION August 4, 2005; ACCEPTED August 15, 2005)

We describe in molecular detail how disruption of an intermonomer salt bridge (Arg337–Asp352) leads to partial destabilization of the p53 tetramerization domain and a dramatically increased propensity to form amyloid fibrils. At pH 4.0 and 37°C, a p53 tetramerization domain mutant (p53tet-R337H), associated with adrenocortical carcinoma in children, readily formed amyloid fibrils, while the wild-type (p53tet-wt) did not. We characterized these proteins by equilibrium denaturation, 13C{alpha} secondary chemical shifts, {1H}-15N heteronuclear NOEs, and H/D exchange. Although p53tet-R337H was thermodynamically less stable, NMR data indicated that the two proteins had similar secondary structure and molecular dynamics. NMR derived pKa values indicated that at low pH the R337H mutation partially disrupted an intermonomer salt bridge. Backbone H/D exchange results showed that for at least a small population of p53tet-R337H molecules disruption of this salt bridge resulted in partial destabilization of the protein. It is proposed that this decrease in p53tet-R337H stability resulted in an increased propensity to form amyloid fibrils.

Keywords: p53 tetramerization domain; amyloid fibrils; salt bridge; pKa; hydrogen exchange

Abbreviations: H/D exchange, hydrogen-deuterium exchange • p53tet, p53 tetramerization domain • p53tet-wt, wild-type p53 tetramerization domain • p53tet-R337H, p53 tetramerization domain mutant R337H • NOE, nuclear Overhauser effect • NOESY, nuclear Overhauser effect spectroscopy • TROSY, transverse relaxation optimized spectroscopy

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051622005.


Reprint requests to: Richard W. Kriwacki, Department of Structural Biology, St. Jude Children’s Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, USA; e-mail: richard.kriwacki{at}stjude.org; fax: (901) 495-3032.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The Protein Society.